Prognostication of Survival in Patients with Advanced Cancer: Predicting the Unpredictable?

Abstract

Background

Prognosis is a key driver of clinical decision-making. However, available prognostication tools have limited accuracy and variable levels of validation.

Methods

Principles of survival prediction and literature on clinician prediction of survival, prognostic factors, and prognostic models were reviewed, with a focus on patients with advanced cancer and a survival rate of a few months or less.

Results

The 4 principles of survival prediction are (a) prognostication is a process instead of an event, (b) prognostic factors may evolve over the course of the disease, (c) prognostic accuracy for a given prognostic factor/tool varies by the definition of accuracy, the patient population, and the time frame of prediction, and (d) the exact timing of death cannot be predicted with certainty. Clinician prediction of survival is the most commonly used approach to formulate prognosis. However, clinicians often overestimate survival rates with the temporal question. Other clinician prediction of survival approaches, such as surprise and probabilistic questions, have higher rates of accuracy. Established prognostic factors in the advanced cancer setting include decreased performance status, delirium, dysphagia, cancer anorexia–cachexia, dyspnea, inflammation, and malnutrition. Novel prognostic factors, such as phase angle, may improve rates of accuracy. Many prognostic models are available, including the Palliative Prognostic Score, the Palliative Prognostic Index, and the Glasgow Prognostic Score.

Conclusions

Despite the uncertainty in survival prediction, existing prognostic tools can facilitate clinical decision-making by providing approximated time frames (months, weeks, or days). Future research should focus on clarifying and comparing the rates of accuracy for existing prognostic tools, identifying and validating novel prognostic factors, and linking prognostication to decision-making.

References

Weeks

J.C.

, Cook

E.F.

, O'Day

S.J.

. Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA. 1998; 279(21): 1709–1714.

Temel

J.S.

, Greer

J.A.

, Admane

. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol. 2011; 29(17): 2319–2326.

Hyman

D.M.

, Eaton

A.A.

, Gounder

M.M.

. Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials. J Clin Oncol. 2014; 32(6): 519–526.

Pond

G.R.

, Siu

L.L.

, Moore

. Nomograms to predict serious adverse events in phase II clinical trials of molecularly targeted agents. J Clin Oncol. 2008; 26(8): 1324–1330.

Miner

T.J.

. Palliative surgery for advanced cancer: lessons learned in patient selection and outcome assessment. Am J Clin Oncol. 2005; 28(4): 411–414.

Casarett

D.J.

, Fishman

J.M.

, Lu

H.L.

. The terrible choice: re-evaluating hospice eligibility criteria for cancer. J Clin Oncol. 2009; 27(6): 953–959.

Lamont

E.B.

, Christakis

N.A.

. Physician factors in the timing of cancer patient referral to hospice palliative care. Cancer. 2002; 94(10): 2733–2737.

Hui

, Bruera

, eds. Internal Medicine Issues in Palliative Cancer Care. 1st ed. Oxford University Press, USA; 2014.

Lamont

E.B.

, Christakis

N.A.

. Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med. 2001; 134(12): 1096–1105.

10.

Glare

P.A.

, Sinclair

C.T.

. Palliative medicine review: prognostication. J Palliat Med. 2008; 11(1): 84–103.

11.

Hui

, Kilgore

, Nguyen

. The accuracy of probabilistic versus temporal clinician prediction of survival for patients with advanced cancer: a preliminary report. Oncologist. 2011; 16(11): 1642–1648.

12.

Llobera

, Esteva

, Rifa

. Terminal cancer. duration and prediction of survival time. Eur J Cancer. 2000; 36(16): 2036–2043.

13.

Hui

, dos Santos

, Reddy

. Acute symptomatic complications among patients with advanced cancer admitted to acute palliative care units: A prospective observational study. Palliat Med. 2015; 29(9): 826–833.

14.

Maltoni

, Caraceni

, Brunelli

. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations — a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol. 2005; 23(25): 6240–6248.

15.

Hui

, Dos Santos

, Chisholm

. Bedside clinical signs associated with impending death in patients with advanced cancer: preliminary findings. Cancer. 2015; 121(6): 960–967.

16.

Hui

, Dos Santos

, Chisholm

. Clinical signs of impending death in cancer patients. Oncologist. 2014; 19(6): 681–687.

17.

Hui

, Mori

, Parsons

. The lack of standard definitions in the supportive and palliative oncology literature. J Pain Symptom Manage. 2012; 43(3): 582–592.

18.

Hui

, Nooruddin

, Didwaniya

. Concepts and definitions for “actively dying,” “end of life,” “terminally ill,” “terminal care,” and “transition of care”: a systematic review. J. Pain Symptom Manage. 2014; 47(1): 77–89.

19.

Tripepi

, Jager

K.J.

, Dekker

F.W.

. Statistical methods for the assessment of prognostic biomarkers (part II): calibration and re-classification. Nephrol Dial Transplant. 2010; 25(5): 1402–1405.

20.

Tripepi

, Jager

K.J.

, Dekker

F.W.

. Statistical methods for the assessment of prognostic biomarkers (Part I): discrimination. Nephrol Dial Transplant. 2010; 25(5): 1399–1401.

21.

Steyerberg

E.W.

, Vergouwe

. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J. 2014; 35(29): 1925–1931.

22.

Steyerberg

E.W.

, Pencina

M.J.

, Lingsma

H.F.

. Assessing the incremental value of diagnostic and prognostic markers: a review and illustration. Eur J Clin Invest. 2012; 42(2): 216–228.

23.

Cook

N.R.

, Paynter

N.P.

. Performance of reclassification statistics in comparing risk prediction models. Biom J. 2011; 53(2): 237–258.

24.

Hosmer

D.W.

, Lemeshow

. Goodness of fit tests for the multiple logistic regression model. Commun Stat. 1980; A9(10): 1043–1069.

25.

Lemeshow

, Hosmer

D.W.

. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982; 115(1): 92–106.

26.

Bruera

, Hui

. Practical model for prognostication in advanced cancer patients: is less more? J Clin Oncol. 2008; 26(36): 5843–5844.

27.

Bruera

, Chisholm

, Dos Santos

. Frequency and factors associated with unexpected death in an acute palliative care unit: expect the unexpected. J Pain Symptom Manage. 2015; 49(5): 822–827.

28.

Casarett

. The median is not the (only) message. Ann Intern Med. 2006; 145(9): 700–701.

29.

Moss

A.H.

, Lunney

J.R.

, Culp

. Prognostic significance of the “surprise” question in cancer patients. J Palliat Med. 2010; 13(7): 837–840.

30.

Perez-Cruz

P.E.

, Dos Santos

, Silva

T.B.

. Longitudinal temporal and probabilistic prediction of survival in a cohort of patients with advanced cancer. J Pain Symptom Manage. 2014; 48(5): 875–882.

31.

Christakis

N.A.

, Lamont

E.B.

. Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort study. BMJ. 2000; 320(7233): 469–472.

32.

Moroni

, Zocchi

, Bolognesi

. The ‘surprise’ question in advanced cancer patients: A prospective study among general practitioners. Palliat Med. 2014; 28(7): 959–964.

33.

Hamano

, Morita

, Inoue

. Surprise questions for survival prediction in patients with advanced cancer: a multicenter prospective cohort study. Oncologist. 2015; 20(7): 839–844.

34.

Elliott

, Nicholson

. A qualitative study exploring use of the surprise question in the care of older people: perceptions of general practitioners and challenges for practice. BMJ Support Palliat Care. 2014. Epub ahead of print.

35.

Kalia

. Biomarkers for personalized oncology: recent advances and future challenges. Metabolism. 2015; 64 (3 suppl 1): S16–S21.

36.

Trajkovic-Vidakovic

, de Graeff

, Voest

E.E.

. Symptoms tell it all: a systematic review of the value of symptom assessment to predict survival in advanced cancer patients. Crit Rev Oncol Hematol. 2012; 84(1): 130–148.

37.

Hui

, Dos Santos

R.D.

, Chisholm

G.B.

. Symptom expression in the last seven days of life among cancer patients admitted to acute palliative care units. J Pain Symptom Manage. 2015; 50(4): 488–494.

38.

Seow

, Barbera

, Sutradhar

. Trajectory of performance status and symptom scores for patients with cancer during the last six months of life. J Clin Oncol. 2011; 29(9): 1151–1158.

39.

Jang

R.W.

, Caraiscos

V.B.

, Swami

. Simple prognostic model for patients with advanced cancer based on performance status. J Oncol Pract. 2014; 10(5): e335–341.

40.

University of Victory School of Health Information Science website. Prognostat. https://htg.his.uvic.ca/tools/PrognosticTools/PalliativePerfor-manceScale/Prognostat/index.php. Accessed October 13, 2015.

41.

Miladinovic

, Mhaskar

, Kumar

. External validation of a web-based prognostic tool for predicting survival for patients in hospice care. J Palliat Care. 2013; 29(3): 140–146.

42.

Mercadante

, Valle

, Porzio

. Prognostic factors of survival in patients with advanced cancer admitted to home care. J Pain Symptom Manage. 2013; 45(1): 56–62.

43.

Vashi

P.G.

, Gupta

, Lammersfeld

C.A.

. The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy. Nutr J. 2013; 12: 118.

44.

Tan

C.S.

, Read

J.A.

, Phan

V.H.

. The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study. Support Care Cancer. 2015; 23(2): 385–391.

45.

Sachlova

, Majek

, Tucek

. Prognostic value of scores based on malnutrition or systemic inflammatory response in patients with metastatic or recurrent gastric cancer. Nutr Cancer. 2014; 66(8): 1362–1370.

46.

Martin

, Senesse

, Gioulbasanis

. Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol. 2015; 33(1): 90–99.

47.

Hui

, Bansal

, Morgado

. Phase angle for prognostication of survival in patients with advanced cancer: preliminary findings. Cancer. 2014; 120(14): 2207–2214.

48.

Caraceni

, Nanni

, Maltoni

. Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer. 2000; 89(5): 1145–1149.

49.

Lawlor

P.G.

, Gagnon

, Mancini

I.L.

. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med. 2000; 160(6): 786–794.

50.

Hui

, De La Cruz

, Bruera

. Palliative care for delirium in patients in the last weeks of life: the final frontier. J Palliat Care. 2014; 30(4): 259–264.

51.

Vigano

, Bruera

, Jhangri

G.S.

. Clinical survival predictors in patients with advanced cancer. Arch Intern Med. 2000; 160(6): 861–868.

52.

Cuervo Pinna

M.A.

, Mota Vargas

, Redondo Moralo

M.J.

. Dyspnea — a bad prognosis symptom at the end of life. Am J Hosp Palliat Care. 2009; 26(2): 89–97.

53.

Gupta

, Lammersfeld

C.A.

, Vashi

P.G.

. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer. BMC Cancer. 2009; 9: 37.

54.

Norman

, Stobaus

, Zocher

. Cutoff percentiles of bio-electrical phase angle predict functionality, quality of life, and mortality in patients with cancer. Am J Clin Nutr. 2010; 92(3): 612–619.

55.

Q.Q.

, Lu

Z.H.

, Yang

. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Asian Pac J Cancer Prev. 2014; 15(2): 945–950.

56.

Suh

S.Y.

, Ahn

H.Y.

. Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study. Eur J Cancer. 2007; 43(6): 1051–1059.

57.

Dev

, Hui

, Del Fabbro

. Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer. Cancer. 2014; 120(10): 1586–1593.

58.

Elsayem

, Mori

, Parsons

H.A.

. Predictors of inpatient mortality in an acute palliative care unit at a comprehensive cancer center. Support Care Cancer. 2010; 18(1): 67–76.

59.

Donovan

P.J.

, Achong

, Griffin

. PTHrP-mediated hypercalcemia: causes and survival in 138 patients. J Clin Endocrinol Metab. 2015; 100(5): 2024–2029.

60.

Maltoni

, Nanni

, Pirovano

; Italian Multicenter Study Group on Palliative Care. Successful validation of the palliative prognostic score in terminally ill cancer patients. J Pain Symptom Manage. 1999; 17(4): 240–247.

61.

Pirovano

, Maltoni

, Nanni

. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage. 1999; 17(4): 231–239.

62.

Glare

P.A.

, Eychmueller

, McMahon

. Diagnostic accuracy of the palliative prognostic score in hospitalized patients with advanced cancer. J Clin. Oncol. 2004; 22(23): 4823–4828.

63.

Tassinari

, Montanari

, Maltoni

. The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy. Support Care Cancer. 2008; 16(4): 359–370.

64.

McMillan

D.C.

. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 2008; 67(3): 257–262.

65.

Hwang

J.E.

, Kim

H.N.

, Kim

D.E.

. Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer. BMC Cancer. 2011; 11: 489.

66.

Jeong

J.H.

, Lim

S.M.

, Yun

J.Y.

. Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer. Oncology. 2012; 83(5): 292–299.

67.

Jiang

A.G.

, Lu

H.Y.

. The Glasgow prognostic score as a prognostic factor in patients with advanced non-small cell lung cancer treated with cisplatin-based first-line chemotherapy. J Chemother. 2015; 27(1): 35–39.

68.

Miura

, Matsumoto

, Hama

. Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan-prognostic assessment tools validation (J-ProVal) study. Support Care Cancer. 2015; 23(11): 3149–3156.

69.

Yoon

S.J.

, Jung

J.G.

, Kim

J.S.

. Retrospective assessment of objective prognostic score in terminally ill Korean patients with cancer. Am J Hosp Palliat Care. 2014; 31(4): 435–440.

70.

Chuang

R.B.

, Hu

W.Y.

, Chiu

T.Y.

. Prediction of survival in terminal cancer patients in Taiwan: constructing a prognostic scale. J Pain Symptom Manage. 2004; 28(2): 115–122.

71.

Al-Zahrani

A.S.

, El-Kashif

A.T.

, Mohammad

A.A.

. Prediction of in-hospital mortality of patients with advanced cancer using the Chuang Prognostic Score. Am J Hosp Palliat Care. 2013; 30(7): 707–711.

72.

Yun

Y.H.

, Heo

D.S.

, Heo

B.Y.

. Development of terminal cancer prognostic score as an index in terminally ill cancer patients. Oncol Rep. 2001; 8(4): 795–800.

73.

Bruera

, Miller

M.J.

, Kuehn

. Estimate of survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manage. 1992; 7(2): 82–86.

74.

Hung

C.Y.

, Wang

H.M.

, Kao

C.Y.

. Magnitude of score change for the palliative prognostic index for survival prediction in patients with poor prognostic terminal cancer. Support Care Cancer. 2014; 22(10): 2725–2731.

75.

Morita

, Tsunoda

, Inoue

. The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer. 1999; 7(3): 128–133.

76.

Sonoda

, Yamaguchi

, Matsumoto

. Validation of the palliative prognostic index and palliative prognostic score in a palliative care consultation team setting for patients with advanced cancers in an acute care hospital in Japan. Am J Hosp Palliat Care. 2014; 31(7): 730–734.

77.

Stone

C.A.

, Tiernan

, Dooley

B.A.

. Prospective validation of the palliative prognostic index in patients with cancer. J Pain Symptom Manage. 2008; 35(6): 617–622.

78.

Alshemmari

, Ezzat

, Samir

. The palliative prognostic index for the prediction of survival and in-hospital mortality of patients with advanced cancer in Kuwait. J Palliat Med. 2012; 15(2): 200–204.

79.

Subramaniam

, Thorns

, Ridout

. Accuracy of prognosis prediction by PPI in hospice inpatients with cancer: a multi-centre prospective study. BMJ Support Palliat Care. 2013; 3(3): 324–329.

80.

Hamano

, Kizawa

, Maeno

. Prospective clarification of the utility of the palliative prognostic index for patients with advanced cancer in the home care setting. Am J Hosp Palliat Care. 2014; 31(8): 820–824.

81.

Scarpi

, Maltoni

, Miceli

. Survival prediction for terminally ill cancer patients: revision of the palliative prognostic score with incorporation of delirium. Oncologist. 2011; 16(12): 1793–1799.

82.

McMillan

D.C.

, Crozier

J.E.

, Canna

. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis. 2007; 22(8): 881–886.

83.

Suh

S.Y.

, Choi

Y.S.

, Shim

J.Y.

. Construction of a new, objective prognostic score for terminally ill cancer patients: a multicenter study. Support Care Cancer. 2010; 18(2): 151–157.

84.

Kelly

, White

, Stone

P.C.

. The B12/CRP index as a simple prognostic indicator in patients with advanced cancer: a confirmatory study. Ann Oncol. 2007; 18(8): 1395–1399.

85.

Geissbuhler

, Mermillod

, Rapin

C.H.

. Elevated serum vitamin B12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: a prospective study over five years. J Pain Symptom Manage. 2000; 20(2): 93–103.

86.

Hyodo

, Morita

, Adachi

. Development of a predicting tool for survival of terminally ill cancer patients. Jpn J Clin Oncol. 2010; 40(5): 442–448.

87.

Maltoni

, Scarpi

, Pittureri

. Prospective comparison of prognostic scores in palliative care cancer populations. Oncologist. 2012; 17(3): 446–454.

88.

Stiel

, Bertram

, Neuhaus

. Evaluation and comparison of two prognostic scores and the physicians’ estimate of survival in terminally ill patients. Support Care Cancer. 2010; 18(1): 43–49.

89.

Baba

, Maeda

, Morita

. Survival prediction for advanced cancer patients in the real world: a comparison of the Palliative Prognostic Score, Delirium-Palliative Prognostic Score, Palliative Prognostic Index and modified Prognosis in Palliative Care Study predictor model. Eur J Cancer. 2015; 51(12): 1618–1629.

90.

Kao

C.Y.

, Hung

Y.S.

, Wang

H.M.

. Combination of initial palliative prognostic index and score change provides a better prognostic value for terminally ill cancer patients: a six-year observational cohort study. J Pain Symptom Manage. 2014; 48(5): 804–814.